Cell line · CVCL_0023
A-549
Cancer cell line, Homo sapiens. Lung adenocarcinoma. 863 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. A-549. Cell lines, record CVCL_0023. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0023
On this page
Cell line
As Cellosaurus gives it.
- Name
- A-549
- Accession
- CVCL_0023
- RRID
- RRID:CVCL_0023
- Synonyms
- A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 58Y
- Category
- Cancer cell line
- Diseases
- Lung adenocarcinoma (NCIt C3512)
- Derived from
- Lung (in situ)
- Secondary accessions
- CVCL_H249
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers863
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 43004984 | Yale J Biol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacokinetic Tuning Redirects β‐Lapachone From NQO1 Bioactivation to Vimentin‐Targeted Oxidation in Cancer | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hypoxic Preconditioning Restores NK Cell Metabolic Fitness by Attenuating MAPK Signaling to Potentiate Antitumor Immunity in Lung Cancer | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 42999416 | Transl Lung Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PIKfyve inhibition induces LRRK2 activation through phosphatidylinositol 3-phosphate and CASM | Life Sci Alliance | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mucin-rich environment shapes Pseudomonas aeruginosa cytotoxicity and phage-mediated epithelial protection. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genetically engineered RNA inducers of proximity for protein regulation. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Comparison of Chemical Components, Anti-Inflammatory Effect and Cytotoxicity to Cancer Cells of Essential Oils From Different Parts of Celosia argentea. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Photodynamic and Cytotoxic Evaluation of Euphorbia anacampseros Methanolic Extract: Chemical Characterization, Molecular Docking, and Light-Activated Anticancer Activity. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 863
See all 863 papersRelatives2,001
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | A549 ATGL-KO | CVCL_UJ32 | Cell lines | |
| Derived from it | A549 B2M KO | CVCL_C3CC | Cell lines | |
| Derived from it | A549 BLTP3A KO clone C2 | CVCL_E9W1 | Cell lines | |
| Derived from it | A549 BLTP3A KO clone D9 | CVCL_E9W2 | Cell lines | |
| Derived from it | A549 BLTP3A-V5 clone B6 | CVCL_E9W3 | Cell lines | |
| Derived from it | A549 BLTP3A-V5 clone C5 | CVCL_E9W4 | Cell lines | |
| Derived from it | A549 Cas9 | CVCL_DX70 | Cell lines | |
| Derived from it | A549 DHODH-/- | CVCL_YZ46 | Cell lines | |
| Derived from it | A549 EGFR Biosensor | CVCL_C3ET | Cell lines | |
| Derived from it | A549 EGFR Knockout | CVCL_C3DB | Cell lines |
1 to 10 of 2,001
See all 2,001 relativesCell banks33
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CCL-185 | ATCC | |
| ATCC | CRL-7909 | Discontinued | Cellosaurus |
| ATCC | CRM-CCL-185 | ATCC | |
| Abcam | ab255450 | Abcam | |
| Abcam | ab259777 | Abcam | |
| Abcam | ab275463 | Abcam | |
| Abcam | ab288558 | Abcam | |
| AddexBio | C0016002/23 | Cellosaurus | |
| BCRC | 60074 | BCRC | |
| BCRJ | 0033 | BCRJ |
1 to 10 of 33
See all 33 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0023
GET https://conductscience.org/api/cell-lines/v1/CVCL_0023/papers?page=2